Competition body rules that drug companies “abused” their positionBMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7421.946-a (Published 23 October 2003) Cite this as: BMJ 2003;327:946
- Pat Sidley
South Africa's competition regulatory body has ruled in favour of AIDS activists who want protection of patents on antiretroviral drugs to be drastically curtailed so that South African makers of generic drugs will be able to produce cheap copies of the drugs.
The Competition Commission ruled in favour of 10 complainants (including the trade union federation and several doctors and nurses) who sought to prove that GlaxoSmithKline and Boehringer Ingelheim abused their …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial